Yaosuo Xue is a Distinguished R&D Staff at ORNL. He joined in ORNL in 2015 from Siemens Corporate Research where he had been leading Siemens North American Corporate power electronics R&D since 2009.

Introduction The purpose of this study is to evaluate the safety and efficacy of two different antithrombotic strategies, dual antiplatelet therapy (DAPT, aspirin and ticagrelor) and direct oral ...